Tossvet Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 18-12-2024
- Paid Up Capital ₹ 1.00 M
as on 18-12-2024
- Company Age 2 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 18-12-2024
About Tossvet Pharmaceuticals India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 Cr.
Ramesh Ramnath, Tejas Karanje, Omkar Shinde, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290PN2022PTC215406
- Company No.
215406
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tossvet Pharmaceuticals India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Ramnath  | Director | 10-Aug-2023 | Current |
| Tejas Karanje | Director | 12-Oct-2022 | Current |
| Omkar Shinde | Director | 12-Oct-2022 | Current |
| Dinesh Karanje | Director | 12-Oct-2022 | Current |
Financial Performance of Tossvet Pharmaceuticals India.
Enhance accessibility to Tossvet Pharmaceuticals India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tossvet Pharmaceuticals India?
Unlock access to Tossvet Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Supernatural Business Services Private LimitedActive 3 years 4 monthsRamesh Ramnath is a mutual person
Karanje-Surana Constructions Private LimitedActive 8 years 10 monthsDinesh Karanje is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2024 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Tossvet Pharmaceuticals India?
Unlock and access historical data on people associated with Tossvet Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tossvet Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tossvet Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.